Skip to main content
. 2023 Apr 18;29:319–328. doi: 10.1016/j.omtm.2023.04.003

Table 1.

Retinal thicknesses with various promoters

Promoter Genotype Mean NFL to RPE thickness (μm)
Mean OPL to RPE thickness (μm)
2 months 4 months 2 months 4 months
CASI WT 222.46 210.75 125.42 119.04
Nnmnat1V9M/V9M 215.95 191.6 119.1 106.45
hGRK1 WT 222.53 217.27 125.69 122.97
Nnmnat1V9M/V9M 201.03 182.89 102.93 93.5
ProC1 WT 222.92 217.56 128.06 124.72
Nnmnat1V9M/V9M 203.88 182.56 109.03 95.34
VMD2 WT 214.25 210.67 124.08 123.25
Nnmnat1V9M/V9M 163.25 146.34 71.7 58.9
ProC3 WT 221.79 219.9 124.29 124.81
Nnmnat1V9M/V9M 194.25 180.6 101.5 93.34
ProD5 WT 222.36 217.36 126.32 124.07
Nnmnat1V9M/V9M 201.2 185.41 108.83 101.88
Untreated WT 226.61 221.99 130.47 128.85
Nnmnat1V9M/V9M 154.8 125.25 61.66 39.09

Mean retinal thickness measured from the nerve fiber layer (NFL) to the retinal pigment epithelium (RPE) or the outer plexiform layer (OPL) to the RPE at 2 months and 4 months of age. Measurements represent the thickness in the inferior region of the retina (closest to the injection site). All treated eyes were treated with scAAV9 with the respective promoter driving expression of hNMNAT1. The virus was delivered at 1E9 vg/μL and co-injected with AAV9 CMV.GFP at a titer of 1E8 vg/μL. WT, wild type.